Mobile

Single- and Multiple-Dose Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Sodium Oxybate (Xyrem®) in Subjects with Moderate to Severe Essential Tremor

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-002222-30

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the relationship between drug plasma levels and safety, tolerability, and efficacy in subjects with moderate to severe essential tremor after single and multiple doses of sodium oxybate.

Critère d'inclusion

  • Patients undergoing moderate or severe classic essential tremor

Liens